PharmX Technologies LimitedASX: PHX

Appendix 4E & FY26 Annual Report

· Issued by PharmX Technologies Limited

Filed with ASX · · 59 pages · English

Summary by 6ix AI

The report highlights a revenue increase from operations, although the company reported a loss before tax due to various non-cash items and ongoing investments. The filing also notes that no dividends were declared during the current or prior financial years, and the financial statements have been audited with an unmodified opinion issued.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

PharmX Technologies Limited on 6ix

Earlier from PharmX Technologies

Later from PharmX Technologies

All PharmX Technologies news releases